A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally

Clinical Trial Summary

The Primary purpose of this study is to evaluate the safety of SHR-1316 plus concurrent chemoradiotherapy in participants with locally advanced cervical cancer. The second purpose of this study is to evaluate the efficacy and PK traits; The exploratory study is to explore the biomarker 、immunogenicity and so on .

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03225443` - Observation and Evaluation of Short-term Curative Effect of Local Advanced Cervical Cancer Treated With Particle Radiotherapy Versus Neoadjuvant Chemotherapy	N/A
Recruiting	`NCT06079671` - Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)	Phase 3
Completed	`NCT05059119` - Rectovaginal Fistula in Post-Radiotherapy Advanced Cervical Cancer Patients
Recruiting	`NCT06055738` - Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC	Phase 2
Recruiting	`NCT06156514` - Evaluation of Concomitant Chemo-radiotherapy With Cisplatine vs Gemcitabin in Locally Advanced Cervicouterine Cancer	Phase 3
Completed	`NCT03298893` - Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months	Phase 1/Phase 2
Withdrawn	`NCT01514955` - An Initial Feasibility Study to Integrate MRI Based Brachytherapy and CT/MR Fused INRT in Treatment of Advance Cervical Cancer	Phase 1
Recruiting	`NCT05950087` - Study on the Relationship Between Plasma MRD and cfDNA HPV and the Efficacy and Prognosis of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy
Recruiting	`NCT04884906` - Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer	Phase 2
Not yet recruiting	`NCT05799469` - Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer	Phase 2
Recruiting	`NCT05311566` - PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer	Phase 2
Terminated	`NCT02045433` - Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer	Phase 2
Not yet recruiting	`NCT06288360` - Neoadjuvant Immunochemotherapy in PD-L1-negative LACC	Phase 2
Not yet recruiting	`NCT06288373` - Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC	Phase 2/Phase 3
Recruiting	`NCT06068387` - A Prospective Study on the Prediction Model of Para-aortic Lymph Node Metastasis	N/A
Recruiting	`NCT05378087` - Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer	N/A
Recruiting	`NCT03963882` - NAC Followed by RH for the Treatment of LACC	Phase 2
Recruiting	`NCT01938105` - Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer	Phase 2
Active, not recruiting	`NCT01793701` - Intensity-modulated Radiotherapy for Locally Advanced Cervical Cancer	Phase 1/Phase 2
Completed	`NCT01230996` - Dose Escalation Study of Simultaneous Boost Intensity-Modulated Radiotherapy for Locally Advanced Cervical Cancer	Phase 1/Phase 2

NCT number	NCT06237257
Study type	Interventional
Source	Shanghai Shengdi Pharmaceutical Co., Ltd
Contact	Yong Cao
Phone	+0518-81220121
Email	caoyong@hrs.com.cn
Status	Recruiting
Phase	Phase 2
Start date	March 20, 2024
Completion date	January 31, 2025

A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms